Carrie Mendivil | Investor Relations |
Chad Robins | Co-founder and Chief Executive Officer |
Julie Rubinstein | President |
Chad Cohen | Chief Financial Officer |
Harlan Robins | Chief Scientific Officer and Co-Founder |
Brian Weinstein | William Blair |
Subbu Nambi | Cowen |
Ivy Ma | Bank of America |
Max Smock | BTIG |
David Westenberg | Guggenheim Securities |
Good day, ladies and gentlemen, and welcome to Adaptive Biotechnologies’ Fourth Quarter Financial Results Call. [Operator Instructions] I would now like to turn the call over to Carrie Mendivil. Ma’am, the floor is yours.
Thank you. Earlier today, Adaptive Biotechnologies released financial results for the fourth quarter and full year ended December 31, 2019.